It has been shown that PDS5B protein behaves as a tumour suppressor, as PDS5B gene expression level is reduced in gastric and colorectal cancers [225], and about 47% of breast cancer have low expression of PDS5B [226]. This evidence concerns the gene PDS5B and neoplasm.